Microbiota-dependent mechanism of Jianpiyifei II in treating experimental virus-induced acute exacerbation of chronic obstructive pulmonary disease
JPYF II alleviated pulmonary inflammation, enhanced lung function, and reduced damage to lung structure and viral replication in a virus-induced AECOPD mouse model. The mechanisms involved the improvement of gut microbiota composition. Furthermore, JPYF II suppressed immune responses and the formation of emphysema by inhibiting the JAK-STAT signaling pathway, with these effects being dependent on the gut microbiota.
Authors
- Huameng Li
- Jingyu Quan
- Long Fan
- Xuhua Yu
- Miaona Zhang
- Lin Lin
- Zhihang Liu
- Ting Cao
- Lei Wu
- Ziyao Liang
Institutions
- Guangzhou University of Chinese Medicine (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1016/j.phymed.2026.157891
- Primary Topic
- Andrographolide Research and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00